Abdul Mannan Explains How DOACs Can Confuse Lupus Anticoagulant Testing
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, has shared a post on LinkedIn:
“Late on a Friday, Dr. Jones reviewed a DRVVT:
• Screen: prolonged
• Mix: no correction
• Confirm: completely normalised
With a confident grin, he declared: ‘Classic Lupus Anticoagulant.’
Diagnosis: Antiphospholipid Syndrome.
Actually, the patient was on rivaroxaban.
The apparent ‘LA’ was nothing more than a DOAC in disguise, and the confirm reagent just happened to mask the culprit.
Moral of the story
Before calling ‘Eureka!’ in the coagulation lab, always check for anticoagulants. DOACs can mimic lupus anticoagulant and mislead even the most confident interpretation.
Learning point
Pre-analytical details are not small print. They are often the hidden plot twists in coagulation testing.”
For more information, check here.
Don’t miss the latest updates with Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis